Eli Lilly Stock (LLY) in Focus as Alzheimer’s Blood Test Gets FDA Approval
The test has already been approved in Europe.
Roche Holdings Ltd-Spons Adr (RHHBY)
This company is not actively trading or the ticker does belong to another company in our database now.
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Ancora Advisors Frederick Disanto | 589 | $30,245 | -41% | 0% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,970,729 | $101,329,037 | 0.21% | |
| 2. | 1,188,687 | $61,039,077 | 3.34% | |
| 3. | 300,155 | $15,412,959 | 0.91% | |
| 4. | 287,612 | $14,832,437 | 0.3% | |
| 5. | 190,302 | $9,772,042 | 1.86% |
News See All
Vanguard Dividend ETFs Comparison: VYMI vs. VIG vs. VYM for Income Investors
Dividend ETFs remain popular among investors looking for steady income and long-term stability, especially in uncertain markets. Using TipRanks Van...
Eli Lilly Stock (LLY) Falls despite FDA Approval for Alzheimer’s Blood Test Developed with Roche
Shares in Eli Lilly ($LLY) edged lower to around $1,243 per share on Monday morning. This came even after the U.S. Food and Drug Administration (FD...
3 Dividend ETFs Crushing the S&P 500 in 2026
The S&P 500 ($SPX) is up about 14% year-to-date. Using TipRanks’ ETF Comparison tool, we identified three dividend ETFs, the iShares Core High Divi...
SCHD vs. VYMI vs. VIG: Which Is the Best Dividend ETF for Passive Income Investors?
A steady passive income stream means balancing current yield, dividend growth, and geographic exposure. Among the many dividend ETFs available, Sch...
3 Vanguard Dividend ETFs to Boost Passive Income
Dividend investing is a simple way to generate regular income. Vanguard ETFs offer a low-cost way to gain diversified income exposure with lower ri...
SCHD vs. VYMI: Which Dividend ETF Comes Out on Top?
Dividend ETFs are one of the most popular ways to earn passive income, but choosing the right fund isn’t always easy. Among the leading options are...
Nurix Therapeutics Stock (NRIX) Soars 40% After $2.3B Blood Cancer Deal with Roche
Shares in biopharmaceutical company Nurix Therapeutics ($NRIX) soared nearly 40% in pre-market trading after sealing a $2.3 billion blood cancer de...
Is it Wise to Invest in Roche Holding (RHHBY)?
Harding Loevner, an investment management firm, published its “International Equity ADR Fund” fourth-quarter 2021 investor letter – a copy of which can be downloaded here.
Is Roche Holding (RHHBY) A Worthy Stock Investment?
Ariel Investments, an investment management firm, published its "Ariel International & Ariel Global Fund" third-quarter 2021 investor letter – a copy of which can be downloaded here.
Hedge Fund Resource Center